On June 13, the United States Supreme Court unanimously ruled that naturally occurring DNA cannot be subject to patent. The landmark decision was the end of a 4-year court battle between the petitioners in the case, the Association for Molecular Pathology and the molecular genetic testing company Myriad Genetics Laboratories, Inc.
|